메뉴 건너뛰기




Volumn 9, Issue 2, 2009, Pages 355-366

Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-Year follow-up

Author keywords

Acute cellular rejection; African American; Antibody mediated rejection; Campath 1H; Chronic allograft nephropathy; Focal segmental glomerulosclerosis; HIV; Induction; Interstitial fibrosis; Laparoscopic live donor nephrectomy; Pediatric; Steroid avoidance; Steroid free; Tubular atrophy

Indexed keywords

ALEMTUZUMAB; ANTIBODY; CREATININE; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

EID: 58849149853     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02492.x     Document Type: Article
Times cited : (53)

References (60)
  • 1
    • 3042956786 scopus 로고
    • Kidney transplantation in modified recipients
    • Murray JE, Merrill JP, Dammin GJ et al. Kidney transplantation in modified recipients. Ann Surg 1962 156 : 337 355.
    • (1962) Ann Surg , vol.156 , pp. 337-355
    • Murray, J.E.1    Merrill, J.P.2    Dammin, G.J.3
  • 2
    • 0345183785 scopus 로고
    • The reversal of rejection in human renal homografts with subsequent development of homograft tolerance
    • Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963 117 : 385 395.
    • (1963) Surg Gynecol Obstet , vol.117 , pp. 385-395
    • Starzl, T.E.1    Marchioro, T.L.2    Waddell, W.R.3
  • 3
    • 0018756252 scopus 로고
    • Cyclosporin A: A preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants
    • Calne RY, White DJG, Pentlow BD et al. Cyclosporin A: A preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc 1979 11 : 860 864.
    • (1979) Transplant Proc , vol.11 , pp. 860-864
    • Calne, R.Y.1    White, D.J.G.2    Pentlow, B.D.3
  • 4
    • 0024419167 scopus 로고
    • FK 506 for human liver, kidney and pancreas transplantation
    • Starzl TE, Todo S, Fung J et al. FK 506 for human liver, kidney and pancreas transplantation. Lancet 1989 2 : 1000 1004.
    • (1989) Lancet , vol.2 , pp. 1000-1004
    • Starzl, T.E.1    Todo, S.2    Fung, J.3
  • 5
    • 0014054539 scopus 로고
    • The use of heterologous antilymphoid agents in canine renal and liver homotransplantations and in human renal homotransplantations
    • Starzl TE, Marchioro TL, Porter KA et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantations and in human renal homotransplantations. Surg Gynecol Obstet 1967 124 : 301 318.
    • (1967) Surg Gynecol Obstet , vol.124 , pp. 301-318
    • Starzl, T.E.1    Marchioro, T.L.2    Porter, K.A.3
  • 6
    • 0342997229 scopus 로고
    • The use of antilymphocyte globulin in human renal homotransplantations
    • In. Wolstenholme, G.E.W., O'Connor, M., eds. London: J and A Churchill Limited
    • Starzl TE, Porter KA, Iwasaki Y et al. The use of antilymphocyte globulin in human renal homotransplantations. In Wolstenholme GEW, O'Connor M, eds. Antilymphocytic Serum. London : J and A Churchill Limited, 1967 : 4 34.
    • (1967) Antilymphocytic Serum. , pp. 4-34
    • Starzl, T.E.1    Porter, K.A.2    Iwasaki, Y.3
  • 7
    • 0014593715 scopus 로고
    • Anti-serum to cultured human lymphoblasts: Preparation, purification and immunosuppressive properties in man
    • Najarian JS, Simmons RL, Gewurz H et al. Anti-serum to cultured human lymphoblasts: Preparation, purification and immunosuppressive properties in man. Ann Surg 1969 170 : 617 632.
    • (1969) Ann Surg , vol.170 , pp. 617-632
    • Najarian, J.S.1    Simmons, R.L.2    Gewurz, H.3
  • 8
    • 0019447825 scopus 로고
    • Use of monoclonal antibodies to T-cell subsets for immunological monitoring and treatment in recipients of renal allografts
    • Cosimi AB, Colvin RB, Burton RC et al. Use of monoclonal antibodies to T-cell subsets for immunological monitoring and treatment in recipients of renal allografts. N Engl J Med 1981 305 : 308 314.
    • (1981) N Engl J Med , vol.305 , pp. 308-314
    • Cosimi, A.B.1    Colvin, R.B.2    Burton, R.C.3
  • 9
    • 0031586439 scopus 로고    scopus 로고
    • Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients
    • CHIB 201 International Study Group
    • Nashan B, Moore R, Amlot P et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997 350 : 1193 1198.
    • (1997) Lancet , vol.350 , pp. 1193-1198
    • Nashan, B.1    Moore, R.2    Amlot, P.3
  • 10
    • 6844236357 scopus 로고    scopus 로고
    • Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group
    • Vincenti F, Kirkman R, Light S et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998 338 : 161 165.
    • (1998) N Engl J Med , vol.338 , pp. 161-165
    • Vincenti, F.1    Kirkman, R.2    Light, S.3
  • 11
    • 0024204319 scopus 로고
    • Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H
    • Hale G, Dyer MJ, Clark MR et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1988 2 : 1394 1399.
    • (1988) Lancet , vol.2 , pp. 1394-1399
    • Hale, G.1    Dyer, M.J.2    Clark, M.R.3
  • 12
    • 0036277088 scopus 로고    scopus 로고
    • A personal history of the CAMPATH-1H antibody
    • Waldmann H. A personal history of the CAMPATH-1H antibody. Med Oncol 2002 19 (Suppl 3 9.
    • (2002) Med Oncol , vol.19 , pp. 3-9
    • Waldmann, H.1
  • 13
    • 0032490341 scopus 로고    scopus 로고
    • Prope tolerance perioperative campath-1H, and low-dose cyclosporine monotherapy in renal allograft recipients
    • Calne RY, Friend PJ, Moffatt S et al. Prope tolerance perioperative campath-1H, and low-dose cyclosporine monotherapy in renal allograft recipients. Lancet 1998 351 : 1701 1702.
    • (1998) Lancet , vol.351 , pp. 1701-1702
    • Calne, R.Y.1    Friend, P.J.2    Moffatt, S.3
  • 14
    • 0033610681 scopus 로고    scopus 로고
    • Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients
    • Calne R, Moffatt SD, Friend PJ et al. Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999 68 : 1613 1616.
    • (1999) Transplantation , vol.68 , pp. 1613-1616
    • Calne, R.1    Moffatt, S.D.2    Friend, P.J.3
  • 15
    • 0038638396 scopus 로고    scopus 로고
    • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)
    • Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120 129.
    • (2003) Transplantation , vol.76 , pp. 120-129
    • Kirk, A.D.1    Hale, D.A.2    Mannon, R.B.3
  • 16
    • 20544458513 scopus 로고    scopus 로고
    • Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years
    • Watson CJ, Bradley JA, Friend PJ et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years. Am J Transplant 2005 5 : 1347 1353.
    • (2005) Am J Transplant , vol.5 , pp. 1347-1353
    • Watson, C.J.1    Bradley, J.A.2    Friend, P.J.3
  • 17
    • 26644457880 scopus 로고    scopus 로고
    • Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
    • Vathsala A, Ona ET, Tan S-Y et al. Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation. Transplantation 2005 80 : 765 774.
    • (2005) Transplantation , vol.80 , pp. 765-774
    • Vathsala, A.1    Ona, E.T.2    Tan, S.-Y.3
  • 18
    • 0038805159 scopus 로고    scopus 로고
    • Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study
    • Knechtle SJ, Pirsch JD, H Fechner J Jr. et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study. Am J Transplant 2003 3 : 722 730.
    • (2003) Am J Transplant , vol.3 , pp. 722-730
    • Knechtle, S.J.1    Pirsch, J.D.2    H Fechner Jr., J.3
  • 19
    • 33749444584 scopus 로고    scopus 로고
    • Outcomes at three years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation
    • Barth RN, Janus CA, Lillesand CA et al. Outcomes at three years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transplant Int 2006 19 : 885 892.
    • (2006) Transplant Int , vol.19 , pp. 885-892
    • Barth, R.N.1    Janus, C.A.2    Lillesand, C.A.3
  • 20
    • 33644833287 scopus 로고    scopus 로고
    • Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression
    • Flechner SM, Friend PJ, Brockmann J et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 2005 5 : 3009 3014.
    • (2005) Am J Transplant , vol.5 , pp. 3009-3014
    • Flechner, S.M.1    Friend, P.J.2    Brockmann, J.3
  • 21
    • 10644270654 scopus 로고    scopus 로고
    • Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: A single center preliminary experience
    • Tan HP, Kaczorowski DJ, Basu A et al. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: A single center preliminary experience. Transplantation 2004 78 : 1683 1688.
    • (2004) Transplantation , vol.78 , pp. 1683-1688
    • Tan, H.P.1    Kaczorowski, D.J.2    Basu, A.3
  • 22
    • 29544432261 scopus 로고    scopus 로고
    • Steroid-free tacrolimus monotherapy following pretransplant thymoglobulin or Campath and laparoscopy in living donor renal transplantation
    • Tan HP, Kaczorowski DJ, Basu A et al. Steroid-free tacrolimus monotherapy following pretransplant thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transpl Proc 2005 37 : 4235 4240.
    • (2005) Transpl Proc , vol.37 , pp. 4235-4240
    • Tan, H.P.1    Kaczorowski, D.J.2    Basu, A.3
  • 23
    • 33748477306 scopus 로고    scopus 로고
    • Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
    • Tan HP, Kaczorowski DJ, Basu A et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 6 : 2409 2417.
    • (2006) Am J Transplant , vol.6 , pp. 2409-2417
    • Tan, H.P.1    Kaczorowski, D.J.2    Basu, A.3
  • 25
    • 20144389244 scopus 로고    scopus 로고
    • Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath
    • Shapiro R, Basu A, Tan H et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005 200 : 505 515.
    • (2005) J Am Coll Surg , vol.200 , pp. 505-515
    • Shapiro, R.1    Basu, A.2    Tan, H.3
  • 26
    • 33745019088 scopus 로고    scopus 로고
    • Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation
    • Shapiro R, Ellis D, Tan HP et al. Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation. J Pediatr 2006 148 : 813 818.
    • (2006) J Pediatr , vol.148 , pp. 813-818
    • Shapiro, R.1    Ellis, D.2    Tan, H.P.3
  • 27
    • 35748960492 scopus 로고    scopus 로고
    • Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation
    • Shapiro R, Ellis D, Tan HP et al. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007 7 : 2736 2738.
    • (2007) Am J Transplant , vol.7 , pp. 2736-2738
    • Shapiro, R.1    Ellis, D.2    Tan, H.P.3
  • 28
    • 23944434883 scopus 로고    scopus 로고
    • A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
    • Ciancio G, Burke GW, Gaynor JJ et al. A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation 2005 80 : 457 465.
    • (2005) Transplantation , vol.80 , pp. 457-465
    • Ciancio, G.1    Burke, G.W.2    Gaynor, J.J.3
  • 29
    • 33644676984 scopus 로고    scopus 로고
    • Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
    • Kaufman DB, Leventhal JR, Axelrod D et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results. Am J Transplant 2005 5 : 2539 2548.
    • (2005) Am J Transplant , vol.5 , pp. 2539-2548
    • Kaufman, D.B.1    Leventhal, J.R.2    Axelrod, D.3
  • 30
    • 33644882722 scopus 로고    scopus 로고
    • Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results
    • Kaufman DB, Leventhal JR, Gallon LG et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results. Am J Transplant 2006 6 : 331 339.
    • (2006) Am J Transplant , vol.6 , pp. 331-339
    • Kaufman, D.B.1    Leventhal, J.R.2    Gallon, L.G.3
  • 31
    • 4744354630 scopus 로고    scopus 로고
    • Campath-1H in renal transplantation: The University of Wisconsin experience
    • Knechtle SJ, Fernandez LA, Pirsch JD et al. Campath-1H in renal transplantation: The University of Wisconsin experience. Surgery 2004 136 : 754 760.
    • (2004) Surgery , vol.136 , pp. 754-760
    • Knechtle, S.J.1    Fernandez, L.A.2    Pirsch, J.D.3
  • 33
    • 33744906053 scopus 로고    scopus 로고
    • Alemtuzumab (Campath-1H): A systematic review in organ transplantation
    • Morris PJ, Russell NK. Alemtuzumab (Campath-1H): A systematic review in organ transplantation. Transplantation 2006 81 : 1361 1367.
    • (2006) Transplantation , vol.81 , pp. 1361-1367
    • Morris, P.J.1    Russell, N.K.2
  • 34
    • 37549043953 scopus 로고    scopus 로고
    • Alemtuzumab (Campath-1H) in kidney transplantation
    • Ciancio G, Burke GW. Alemtuzumab (Campath-1H) in kidney transplantation. Am J Transplant 2008 8 : 15 20.
    • (2008) Am J Transplant , vol.8 , pp. 15-20
    • Ciancio, G.1    Burke, G.W.2
  • 35
    • 33847761900 scopus 로고    scopus 로고
    • Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
    • Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526.
    • (2007) Am J Transplant , vol.7 , pp. 518-526
    • Solez, K.1    Colvin, R.B.2    Racusen, L.C.3
  • 36
    • 33846222310 scopus 로고    scopus 로고
    • Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival
    • Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007 7 : 864 871.
    • (2007) Am J Transplant , vol.7 , pp. 864-871
    • Terasaki, P.I.1    Ozawa, M.2    Castro, R.3
  • 37
    • 42549117196 scopus 로고    scopus 로고
    • Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody
    • Shapiro R, Zeevi A, Basu A et al. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation 2008 85 : 1125 1132.
    • (2008) Transplantation , vol.85 , pp. 1125-1132
    • Shapiro, R.1    Zeevi, A.2    Basu, A.3
  • 38
    • 33947576549 scopus 로고    scopus 로고
    • Clinical research, innovative practice and IRB review: Identifying and respecting boundaries
    • Ryan CM, Swanson DP. Clinical research, innovative practice and IRB review: Identifying and respecting boundaries. Am J Transplant 2007 7 : 748 750.
    • (2007) Am J Transplant , vol.7 , pp. 748-750
    • Ryan, C.M.1    Swanson, D.P.2
  • 40
    • 0001396036 scopus 로고    scopus 로고
    • Laparoscopic live donor nephrectomy: Evolution of a new standard
    • Tan HP, Maley WR, Kavoussi LR et al. Laparoscopic live donor nephrectomy: Evolution of a new standard. Curr Opin Organ Transplant 2000 12 : 312 318.
    • (2000) Curr Opin Organ Transplant , vol.12 , pp. 312-318
    • Tan, H.P.1    Maley, W.R.2    Kavoussi, L.R.3
  • 41
    • 0036815187 scopus 로고    scopus 로고
    • Laparoscopic live donor nephrectomy
    • Tan HP, Orloff M, Marcos A et al. Laparoscopic live donor nephrectomy. Graft 2002 5 : 404 415.
    • (2002) Graft , vol.5 , pp. 404-415
    • Tan, H.P.1    Orloff, M.2    Marcos, A.3
  • 42
    • 17844363736 scopus 로고    scopus 로고
    • Reversal of acute cellular rejection after renal transplantation with Campath-1H
    • Basu A, Ramkumar M, Tan HP et al. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transpl Proc 2005 37 : 923 926.
    • (2005) Transpl Proc , vol.37 , pp. 923-926
    • Basu, A.1    Ramkumar, M.2    Tan, H.P.3
  • 43
    • 0344666767 scopus 로고    scopus 로고
    • The natural history of chronic allograft nephropathy
    • Nankivell BJ, Borrows RJ, Fung CLS et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326 2333.
    • (2003) N Engl J Med , vol.349 , pp. 2326-2333
    • Nankivell, B.J.1    Borrows, R.J.2    Fung, C.L.S.3
  • 44
    • 34247580226 scopus 로고    scopus 로고
    • Outcome of alemtuzumab pre-conditioning and tacrolimus monotherapy in living donor liver and kidney transplantation
    • Tan HP, Shapiro R, Tom K et al. Outcome of alemtuzumab pre-conditioning and tacrolimus monotherapy in living donor liver and kidney transplantation. Expert Rev Pharmacoeconomics Outcomes Res 2007 7 : 1 6.
    • (2007) Expert Rev Pharmacoeconomics Outcomes Res , vol.7 , pp. 1-6
    • Tan, H.P.1    Shapiro, R.2    Tom, K.3
  • 45
    • 0035754206 scopus 로고    scopus 로고
    • Transplantation tolerance from a historical perspective
    • Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001 1 : 233 239.
    • (2001) Nat Rev Immunol , vol.1 , pp. 233-239
    • Starzl, T.E.1    Zinkernagel, R.2
  • 46
    • 0038298787 scopus 로고    scopus 로고
    • Tolerogenic immunosuppression for organ transplantation
    • Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003 361 : 1502 1510.
    • (2003) Lancet , vol.361 , pp. 1502-1510
    • Starzl, T.E.1    Murase, N.2    Abu-Elmagd, K.3
  • 47
    • 10744225978 scopus 로고    scopus 로고
    • Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning
    • Shapiro R, Jordan ML, Basu A et al. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003 238 : 520 525.
    • (2003) Ann Surg , vol.238 , pp. 520-525
    • Shapiro, R.1    Jordan, M.L.2    Basu, A.3
  • 48
    • 6344256213 scopus 로고    scopus 로고
    • Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus
    • Marcos A, Eghtesad B, Fung JJ et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus. Transplantation 2004 78 : 966 971.
    • (2004) Transplantation , vol.78 , pp. 966-971
    • Marcos, A.1    Eghtesad, B.2    Fung, J.J.3
  • 49
    • 23044511810 scopus 로고    scopus 로고
    • Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy
    • McCurry K, Iacano A, Zeevi A et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005 130 : 528 537.
    • (2005) J Thorac Cardiovasc Surg , vol.130 , pp. 528-537
    • McCurry, K.1    Iacano, A.2    Zeevi, A.3
  • 50
    • 32144464556 scopus 로고    scopus 로고
    • Intestinal transplantation for short gut syndrome and gut failure: Rewarding outcomes and current consensus
    • Abu-Elmagd K. Intestinal transplantation for short gut syndrome and gut failure: Rewarding outcomes and current consensus. Gastroenterology 2006 130 : 132 137.
    • (2006) Gastroenterology , vol.130 , pp. 132-137
    • Abu-Elmagd, K.1
  • 51
    • 33845923314 scopus 로고    scopus 로고
    • Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes
    • Thai NL, Khan A, Tom K et al. Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation 2006 82 : 1621 1624.
    • (2006) Transplantation , vol.82 , pp. 1621-1624
    • Thai, N.L.1    Khan, A.2    Tom, K.3
  • 52
    • 20044380331 scopus 로고    scopus 로고
    • Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion
    • Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005 5 : 465 474.
    • (2005) Am J Transplant , vol.5 , pp. 465-474
    • Pearl, J.P.1    Parris, J.2    Hale, D.A.3
  • 53
    • 31044451821 scopus 로고    scopus 로고
    • T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients
    • Bloom DD, Hu H, Fechner JH et al. T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation 2006 81 : 81 87.
    • (2006) Transplantation , vol.81 , pp. 81-87
    • Bloom, D.D.1    Hu, H.2    Fechner, J.H.3
  • 54
    • 1942454828 scopus 로고    scopus 로고
    • Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients
    • Knechtle SJ. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004 8 : 106 112.
    • (2004) Pediatr Transplant , vol.8 , pp. 106-112
    • Knechtle, S.J.1
  • 55
    • 28544440832 scopus 로고    scopus 로고
    • The evolving role of alemtuzumab in management of patients with CLL
    • Faderl S, Coutre S, Byrd JC et al. The evolving role of alemtuzumab in management of patients with CLL. Leukemia 2005 19 : 2147 2152.
    • (2005) Leukemia , vol.19 , pp. 2147-2152
    • Faderl, S.1    Coutre, S.2    Byrd, J.C.3
  • 56
    • 27744481221 scopus 로고    scopus 로고
    • Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin
    • Kirk AD, Mannon RB, Kleiner DE et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005 80 : 1051 1059.
    • (2005) Transplantation , vol.80 , pp. 1051-1059
    • Kirk, A.D.1    Mannon, R.B.2    Kleiner, D.E.3
  • 57
    • 58849117320 scopus 로고    scopus 로고
    • U.S. Scientific Registry of Transplant Recipients Annual Report 2006. From: Accessed January 10th, 2008.
    • U.S. Scientific Registry of Transplant Recipients Annual Report 2006. From : http://www.ustransplant.org. Accessed January 10th, 2008.
  • 58
    • 0037148938 scopus 로고    scopus 로고
    • Strategies to improve long-term outcomes after renal transplantation
    • Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002 346 : 580 590.
    • (2002) N Engl J Med , vol.346 , pp. 580-590
    • Pascual, M.1    Theruvath, T.2    Kawai, T.3
  • 59
    • 0033780696 scopus 로고    scopus 로고
    • Recommendations for the outpatient surveillance of renal transplant recipients
    • Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. Am Soc Transplant J Am Soc Nephrol 2000 11 (Suppl 15 S1 S86.
    • (2000) Am Soc Transplant J Am Soc Nephrol , vol.11 , Issue.15
    • Kasiske, B.L.1    Vazquez, M.A.2    Harmon, W.E.3
  • 60
    • 26444609695 scopus 로고    scopus 로고
    • Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy
    • Hill P, Gagliardini E, Ruggenenti P, Remuzzi G. Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy. Nephrol Dial Transplant 2005 20 : 1741 1744.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1741-1744
    • Hill, P.1    Gagliardini, E.2    Ruggenenti, P.3    Remuzzi, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.